IP Master Class: Patent Licenses and Licensing Strategies After MedImmune
In MedImmune v. Genentech
, the Supreme Court recently ruled that a patent licensee does not have to breach or terminate a license agreement before bringing an action challenging the scope or validity of a licensed patent. In so doing, the Court may have fundamentally altered the balance of power between patent holders and their licensees. Join this teleconference to hear four Ropes & Gray partners discuss the challenges facing patent holders, licensees and parties to licensing negotiations in the wake of this important opinion.